| |  Online-Ressource |
|---|
| Verfasst von: | Lerchenmüller, Carolin [VerfasserIn]  |
|---|
| | Hastings, Margaret H. [VerfasserIn] |
|---|
| | Rabolli, Charles P. [VerfasserIn] |
|---|
| | Betge, Fynn [VerfasserIn] |
|---|
| | Roshan, Mani [VerfasserIn] |
|---|
| | Liu, Laura X. [VerfasserIn] |
|---|
| | Liu, Xiaojun [VerfasserIn] |
|---|
| | Heß, Chiara [VerfasserIn] |
|---|
| | Roh, Jason D. [VerfasserIn] |
|---|
| | Platt, Colin [VerfasserIn] |
|---|
| | Bezzerides, Vassilios [VerfasserIn] |
|---|
| | Busch, Martin [VerfasserIn] |
|---|
| | Katus, Hugo [VerfasserIn] |
|---|
| | Frey, Norbert [VerfasserIn] |
|---|
| | Most, Patrick [VerfasserIn] |
|---|
| | Rosenzweig, Anthony [VerfasserIn] |
|---|
| Titel: | CITED4 gene therapy protects against maladaptive cardiac remodeling after ischemia/reperfusion injury in mice |
|---|
| Verf.angabe: | Carolin Lerchenmüller, Margaret H. Hastings, Charles P. Rabolli, Fynn Betge, Mani Roshan, Laura X. Liu, Xiaojun Liu, Chiara Heß, Jason D. Roh, Colin Platt, Vassilios Bezzerides, Martin Busch, Hugo A. Katus, Norbert Frey, Patrick Most and Anthony Rosenzweig |
|---|
| E-Jahr: | 2024 |
|---|
| Jahr: | 2 October 2024 |
|---|
| Umfang: | 12 S. |
|---|
| Illustrationen: | Illustrationen |
|---|
| Fussnoten: | Online veröffentlicht: 26. Juli 2024, Artikelversion: 2. Oktober 2024 ; Gesehen am 09.04.2025 |
|---|
| Titel Quelle: | Enthalten in: Molecular therapy |
|---|
| Ort Quelle: | Amsterdam : Elsevier, 2000 |
|---|
| Jahr Quelle: | 2024 |
|---|
| Band/Heft Quelle: | 32(2024), 10, Seite 3683-3694 |
|---|
| ISSN Quelle: | 1525-0024 |
|---|
| Abstract: | Cardiac signaling pathways functionally important in the heart’s response to exercise often protect the heart against pathological stress, potentially providing novel therapeutic targets. However, it is important to determine which of these pathways can be feasibly targeted in vivo. Transgenic overexpression of exercise-induced CITED4 has been shown to protect against adverse remodeling after ischemia/reperfusion injury (IRI). Here we investigated whether somatic gene transfer of CITED4 in a clinically relevant time frame could promote recovery after IRI. Cardiac CITED4 gene delivery via intravenous AAV9 injections in wild type mice led to an approximately 3-fold increase in cardiac CITED4 expression. After 4 weeks, CITED4-treated animals developed physiological cardiac hypertrophy without adverse remodeling. In IRI, delivery of AAV9-CITED4 after reperfusion resulted in a 6-fold increase in CITED4 expression 1 week after surgery, as well as decreased apoptosis, fibrosis, and inflammatory markers, culminating in a smaller scar and improved cardiac function 8 weeks after IRI, compared with control mice receiving AAV9-GFP. Somatic gene transfer of CITED4 induced a phenotype suggestive of physiological cardiac growth and mitigated adverse remodeling after ischemic injury. These studies support the feasibility of CITED4 gene therapy delivered in a clinically relevant time frame to mitigate adverse ventricular remodeling after ischemic injury. |
|---|
| DOI: | doi:10.1016/j.ymthe.2024.07.018 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
kostenfrei: Volltext: https://doi.org/10.1016/j.ymthe.2024.07.018 |
|---|
| | kostenfrei: Volltext: https://www.sciencedirect.com/science/article/pii/S1525001624004726 |
|---|
| | DOI: https://doi.org/10.1016/j.ymthe.2024.07.018 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | cardiac remodeling |
|---|
| | cardioprotection |
|---|
| | exercise |
|---|
| | gene therapy |
|---|
| K10plus-PPN: | 1921981156 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
CITED4 gene therapy protects against maladaptive cardiac remodeling after ischemia/reperfusion injury in mice / Lerchenmüller, Carolin [VerfasserIn]; 2 October 2024 (Online-Ressource)
